Clinical trial
Duloxetine Compassionate Use in Patients Who Have Completed a Previous…
NCT00071708 · Eli Lilly and Company, Industry · Approved for marketing
Key facts
| NCT number | NCT00071708 |
|---|---|
| Title | Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial |
| Official title | Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Approved for marketing |
| Study type | Expanded Access |
| Conditions | Major Depressive Disorder, Fibromyalgia, Diabetic Peripheral Neuropathic Pain, Generalized Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Duloxetine Hydrochloride |
| First posted | Oct 30, 2003 |
| Last update posted | Jan 10, 2025 |
| Countries | Australia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: